(Q33872125)

29 July 2017

title

The antipsychotic drug risperidone interacts with auto- and hetero-receptors regulating serotonin output in the rat frontal cortex (English)

1 reference

29 July 2017

0 references

1 reference

Hertel P

1

1 reference

29 July 2017

Nomikos GG

series ordinal

2

1 reference

29 July 2017

Svensson TH

series ordinal

3

1 reference

29 July 2017

publication date

1 August 1999

1 reference

29 July 2017

number of pages

10

1 reference

inferred from page(s)

published in

Neuropharmacology

1 reference

29 July 2017

volume

38

1 reference

29 July 2017

issue

8

1 reference

29 July 2017

page(s)

1175-1184

1 reference

The role of serotonin in the pathophysiology and treatment of schizophrenia

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

(R)-8-OH-DPAT preferentially increases dopamine release in rat medial prefrontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

The 5-HT1 receptor agonist RU-24969 decreases 5-hydroxytryptamine (5-HT) release and metabolism in the rat frontal cortex in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Serotonin, schizophrenia and antipsychotic drug action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Localization of 5-HT1B, 5-HT1D alpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Autoradiographic characterisation and localisation of 5-HT1D compared to 5-HT1B binding sites in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Serotonin release estimated by transcortical dialysis in freely-moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

The profiles of interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify 5-HT release in the frontal cortex of freely-moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Evidence that 5-hydroxytryptamine release in rat dorsal raphé nucleus is controlled by 5-HT1A, 5-HT1B and 5-HT1D autoreceptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Serotonin efflux in the rat ventral lateral geniculate nucleus assessed by fast cyclic voltammetry is modulated by 5-HT1B and 5-HT1D autoreceptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Studies on RX 781094: a selective, potent and specific antagonist of α2-adrenoceptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Effects of idazoxan on dorsal raphe 5-hydroxytryptamine neuronal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Inhibition of 5-HT cell firing in the DRN by non-selective 5-HT reuptake inhibitors: studies on the role of 5-HT1A autoreceptors and noradrenergic mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

A placebo-controlled trial of fluoxetine added to neuroleptic in patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Adjunctive fluoxetine improves global function in chronic schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Characterization of the receptor subtype involved in alpha-adrenoceptor-mediated modulation of serotonin release from rat brain cortex slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Detection and characterization of the serotonin 5-HT 1D receptor in rat and human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Risperidone dose-dependently increases extracellular concentrations of serotonin in the rat frontal cortex: role of alpha 2-adrenoceptor antagonism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

The putative 5-HT1B receptor agonist CP-93,129 suppresses rat hippocampal 5-HT release in vivo: comparison with RU 24969.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Structure and function of the brain serotonin system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Dopamine, the prefrontal cortex and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Brain imaging in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Clozapine inhibits serotoninergic transmission by an action at alpha 1-adrenoceptors not at 5-HT1A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Species differences in presynaptic serotonin autoreceptors: mainly 5-HT1B but possibly in addition 5-HT1D in the rat, 5-HT1D in the rabbit and guinea-pig brain cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo[3,2-b]pyrid-5-one: a potent and selective serotonin (5-HT1B) agonist and rotationally restricted phenolic analogue of 5-methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl)indole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Effects of idazoxan on dopamine release in the prefrontal cortex of freely moving rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Noradrenaline inhibits central serotonin release through alpha 2-adrenoceptors located on serotonergic nerve terminals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

The putative 5-HT1 receptor agonist, RU 24969, inhibits the efflux of 5-hydroxytryptamine from rat frontal cortex slices by stimulation of the 5-HT autoreceptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

5-HT1D receptors regulate 5-HT release in the rat raphe nuclei. In vivo voltammetry and in vitro superfusion studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Autoregulatory properties of dorsal raphe 5-HT neurons: possible role of electrotonic coupling and 5-HT1D receptors in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Acute dietary tryptophan depletion: effects on schizophrenic positive and negative symptoms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Fluvoxamine improves negative symptoms in treated chronic schizophrenia: an add-on double-blind, placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Augmentation with fluvoxamine but not maprotiline improves negative symptoms in treated schizophrenia: evidence for a specific serotonergic effect from a double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

GR127935: a potent and selective 5-HT1D receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Adjunctive fluoxetine in the treatment of negative symptoms in chronic schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism [corrected]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Local cooling of pre-frontal cortex induces pacemaker-like firing of dopamine neurons in rat ventral tegmental area in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Alpha 2-adrenoceptor modulation of rat ventral hippocampal 5-hydroxytryptamine release in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Effect of nicotine on levels of extracellular amino acids in regions of the rat brain in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Presynaptic alpha 2-autoreceptors in brain cortex: alpha 2D in the rat and alpha 2A in the rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Release-inhibiting alpha 2-adrenoceptors at serotonergic axons in rat and rabbit brain cortex: evidence for pharmacological identity with alpha 2-autoreceptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Regulation of serotonin release in the frontal cortex and ventral hippocampus of homozygous mice lacking 5-HT1B receptors: in vivo microdialysis studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

BIMG 80, a novel potential antipsychotic drug: evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and chronic nicotine-treated rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

7 January 2021

inferred from DOI database lookup

Functional mapping of dorsal and median raphe 5-hydroxytryptamine pathways in forebrain of the rat using microdialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

7 January 2021

inferred from DOI database lookup

Regulation of extracellular dopamine by the norepinephrine transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900045-3

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0028-3908(99)00045-3

1 reference

29 July 2017

1 reference